Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Overcoming refractory massive proteinuria remains a clinical and research issue in diabetic nephropathy. This study was designed to investigate the pathogenesis of massive proteinuria in diabetic nephropathy, with a special focus on podocyte autophagy, a system of intracellular degradation that maintains cell and organelle homeostasis, using human tissue samples and animal models. Insufficient podocyte autophagy was observed histologically in patients and rats with diabetes and massive proteinuria accompanied by podocyte loss, but not in those with no or minimal proteinuria. Podocyte-specific autophagy-deficient mice developed podocyte loss and massive proteinuria in a high-fat diet (HFD)–induced diabetic model for inducing minimal proteinuria. Interestingly, huge damaged lysosomes were found in the podocytes of diabetic rats with massive proteinuria and HFD-fed, podocyte-specific autophagy-deficient mice. Furthermore, stimulation of cultured podocytes with sera from patients and rats with diabetes and massive proteinuria impaired autophagy, resulting in lysosome dysfunction and apoptosis. These results suggest that autophagy plays a pivotal role in maintaining lysosome homeostasis in podocytes under diabetic conditions, and that its impairment is involved in the pathogenesis of podocyte loss, leading to massive proteinuria in diabetic nephropathy. These results may contribute to the development of a new therapeutic strategy for advanced diabetic nephropathy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, a high-fat diet induced minimal proteinuria in wild-type mice, but podocyte-specific Atg5-knockout mice developed substantial albuminuria accompanied by severe tubulointerstitial lesions and injury to podocytes, which accumulated damaged lysosomes.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [128]
In the citing paper
“Another study showed that podocyte autophagy was impaired in patients with type 2 diabetes, as well as in OLETF rats (that is, rats with obesity-induced diabetes), with severe proteinuria, but not in those with no or minimal proteinuria128.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [128]
In the citing paper
“suggesting that serum-derived factors might negatively regulate podocyte autophagy as DKD progresses128.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [128]
In the citing paper
“Interestingly, stimulating cultured podocytes with serum from patients with type 2 diabetes or OLETF rats with severe proteinuria inhibited autophagy and induced lysosomal dysfunction and apoptosis”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [128]
Citations
Cites
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227 · cited 1×
“The mammalian target of rapamycin complex 1 (mTORC1) is a nutrient-sensing signal that inhibits autophagy (49).”
BackgroundAutophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452 · cited 1×
“Autophagy is an evolutionarily conserved intracellular catabolic process that allows for the degradation of proteins and organelles via the lysosomal pathway (5,6).”
BackgroundAutophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418 · cited 1×
“Autophagy is an evolutionarily conserved intracellular catabolic process that allows for the degradation of proteins and organelles via the lysosomal pathway (5,6).”
BackgroundPankiv, S., Clausen, T. H., Lamark, T., Brech, A., Bruun, J.-A., Outzen, H., Øvervatn, A., Bjørkøy, G., & Johansen, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702824200 · Cited by 4,578 · cited 1×
“The protein p62 is a specific target of the autophagy degradation; thus, intracellular accumulation of this protein is indicative of insufficient autophagy (37).”
BackgroundMethods in Mammalian Autophagy Research
Mizushima, N., Yoshimori, T., & Levine, B. (2010) · Cell · doi:10.1016/j.cell.2010.01.028 · Cited by 4,497 · cited 1×
“Complement was depleted by heat inactivation, and cells were incubated in 10% serum for 24 h (29,30), with/without lysosome inhibitors for 1 h (31).”
MethodAutophagy and the Integrated Stress Response
Kroemer, G., Mariño, G., & Levine, B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.023 · Cited by 3,506 · cited 1×
“Autophagy can degrade many damaged proteins and organelles (7).”
BackgroundThe role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865 · cited 3×
“The protein coded by the Atg5 gene is essential for autophagosome formation (21).”
BackgroundImpairment of starvation-induced and constitutive autophagy in Atg7 -deficient mice
Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., Mizushima, N., Ohsumi, Y., Uchiyama, Y., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200412022 · Cited by 2,331 · cited 2×
“Glomeruli of podocyte-specific Atg7deficient (33,34) and wild-type mice were isolated using Dynabeads M-450 Tosylactivated (Invitrogen, Carlsbad, CA) (35).”
BackgroundMethodMizushima, N., Yamamoto, A., Matsui, M., Yoshimori, T., & Ohsumi, Y. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-09-0704 · Cited by 2,105 · cited 2×
“Interestingly, autophagy activity in podocytes is constitutively high, even under nonstress conditions (18,19), suggesting that the autophagylysosome system plays a pivotal role in maintaining podocyte homeostasis and that its alteration is involved in the pathogenesis of diabetic nephropathy.”
BackgroundMethodRabinowitz, J. D., & White, E. (2010) · Science · doi:10.1126/science.1193497 · Cited by 1,982
Cited by
Items 101–200 of 315
Lu, J. G., Chen, P. P., Zhang, J. X., Li, X. Q., Wang, G. H., Yuan, B. Y., Huang, S. J., Liu, X. Q., Jiang, T. T., Wang, M. Y., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.64665 · Cited by 45
“Previous studies have revealed that podocyte-specific deletion of ATG5 (encoding a protein that is important for phagocytic membrane elongation) leads to autophagy arrest, which results in proteinuria and increased susceptibility to glomerular diseases such as DN and focal segmental glomerulosclerosis [39, 40].”
BackgroundHao, J., Xiaotian, L., Tang, J., Xueying, C., Honge, J., Bo, Z., Hao, L., & Zhang, L. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1668000 · Cited by 44
Autophagy and lysosomal dysfunction in diabetes and its complications
Arden, C., Park, S. H., Yasasilka, X. R., Lee, E. Y., & Lee, M. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.06.010 · Cited by 47
Kaufman, D. R., Papillon, J., Larose, L., Iwawaki, T., & Cybulsky, A. V. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-12-0828 · Cited by 41
“Deficient autophagy in podocytes was shown to worsen proteinuria and podocyte loss in a murine model of diabetic nephropathy (Tagawa et al., 2016).”
BackgroundA reciprocal regulation of spermidine and autophagy in podocytes maintains the filtration barrier
Liang, W., Yamahara, K., Hernando-Erhard, C., Lagies, S., Wanner, N., Liang, H., Schell, C., Kammerer, B., Huber, T. B., & Bork, T. (2020) · Kidney International · doi:10.1016/j.kint.2020.06.016 · Cited by 39
Self-citationCai, R., & Jiang, J. (2020) · Inflammation · doi:10.1007/s10753-020-01282-1 · Cited by 44
“A previous study reported that podocytes play pivotal roles in maintaining the glomerular filtration barrier [9], the loss and impairment of which will result in massive proteinuria in DN patients [10].”
BackgroundPathogenesis and damage targets of hypertensive kidney injury
Sun, D., Wang, J., Shao, W., Wang, J., Yao, L., Li, Z., & Ohno, S. (2020) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2020-0033 · Cited by 53
Xuan, C., Xi, Y.-M., Zhang, Y., Tao, C.-H., Zhang, L., & Cao, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.624404 · Cited by 42
“Numerous studies have shown that the level of podocyte autophagy is inhibited in DN, and promoting autophagy is a promising potential mechanism for the treatment of DN (Kume et al., 2014; Tagawa et al., 2016).”
BackgroundThe role of autophagy in the treatment of type II diabetes and its complications: a review
Zhao, X., Bie, L., Pang, D.-R., Li, X., Yang, L., Chen, D., Wang, Y.-R., & Gao, Y. J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1228045 · Cited by 41
“In a high-fat diet (HFD)-induced diabetes model, podocyte-specific autophagy-deficient mice showed a loss of renal podocytes and massive proteinuria (86).”
BackgroundPodocyte Death in Diabetic Kidney Disease: Potential Molecular Mechanisms and Therapeutic Targets
Zhong, S., Wang, N., & Zhang, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169035 · Cited by 48
“Many researches indicate that autophagy plays a crucial role in preserving lysosomal homeostasis in podocytes under diabetic conditions, and its dysfunction is instrumental in the pathogenesis of podocyte loss, ultimately resulting in increased proteinuria in DKD [74].”
BackgroundObesity-Related Glomerulopathy: From Mechanism to Therapeutic Target
Wei, L., Li, Y., Yu, Y., Xu, M., Chen, H., Li, L., Peng, T., Zhao, K., & Zhuang, Y. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s334199 · Cited by 46
Zhang, Y., Chang, B., Zhang, J., & Wu, X. (2019) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2019.104283 · Cited by 37
Vitamin D/VDR Protects Against Diabetic Kidney Disease by Restoring Podocytes Autophagy
Song, Z., Xiao, C., Jia, X., Chunhua, L., Shi, L., Xia, R. M., Zhu, J., & Zhang, S. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s303018 · Cited by 37
Liu, P., Zhang, J., Wang, Y., Shen, Z., Wang, C., Chen, D., & Qiu, X. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.747922 · Cited by 43
Geng, M., Wang, L., Song, Y., Gu, J., Hu, X., Yuan, C., Yang, M., Pei, W., Zhang, Y., & Gao, J. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04453-6 · Cited by 40
Therapeutic Potential of Resveratrol in Diabetic Nephropathy According to Molecular Signaling
Salami, M., Salami, R., Mafi, A., Aarabi, M. H., Vakili, O., & Asemi, Z. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467215666211217122523 · Cited by 38
Irisin ameliorates diabetic kidney disease by restoring autophagy in podocytes
Lai, W., Luo, D., Li, Y., Li, Y., Wang, Q., Hu, Z., Ye, Z., & Peng, H. (2023) · The FASEB Journal · doi:10.1096/fj.202300420r · Cited by 43
GDF-15 alleviates diabetic nephropathy via inhibiting NEDD4L-mediated IKK/NF-κB signalling pathways
Zhang, X., Wang, S., Chong, N., Chen, D., Shu, J., Sun, J., Sun, Z., Wang, R., Wang, Q., & Xu, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111427 · Cited by 44
Yang, H., Sun, J., Sun, A., Yu, W., Xie, W., Xie, P., Zhang, L., Zhao, L., & Huang, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117140 · Cited by 44
Three-dimensional imaging of podocyte ultrastructure using FE-SEM and FIB-SEM tomography
Miyaki, T., Kawasaki, Y., Hosoyamada, Y., Amari, T., Kinoshita, M., Matsuda, H., Kakuta, S., Sakai, T., & Ichimura, K. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03118-3 · Cited by 36
Jin, D., Liu, F., Yu, M., Zhao, Y., Yan, G., Xue, J., Sun, Y., Zhao, D., Li, X., Qi, W., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115246 · Cited by 37
Ezzat, S. M., Abdallah, H. M. I., Yassen, N. N., Radwan, R. A., Mostafa, E. S., Salama, M. M., & Salem, M. A. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111948 · Cited by 37
Genistein and Myd88 Activate Autophagy in High Glucose-Induced Renal Podocytes In Vitro
Wang, Y., Li, Y., Zhang, T., Chi, Y., Liu, M., & Liu, Y. (2018) · Medical Science Monitor · doi:10.12659/msm.910868 · Cited by 37
“Furthermore, longterm exposure of primary rat podocytes to HG promoted podocyte injury, and attenuation of autophagy further deteriorated this process [40].”
BackgroundAMPK allostery: A therapeutic target for the management/treatment of diabetic nephropathy
Ayinde, K. S., Olaoba, O. T., Boyenle, I. D., Du, L., Lü, Q., Yin, X., & Adelusi, T. I. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118455 · Cited by 37
Teh, Y. M., Mualif, S. A., & Lim, S. K. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.106153 · Cited by 40
Autophagy and Mitophagy in Diabetic Kidney Disease—A Literature Review
Stăniguț, A. M., Tuta, L. A., Pana, C., Alexandrescu, L., Suceveanu, A. P., Blebea, N. M., & Văcăroiu, I. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020806 · Cited by 42
“These results suggest that impaired autophagy can cause podocyte lesions in DN with important proteinuria [107].”
Muratsubaki, S., Kuno, A., Tanno, M., Miki, T., Yano, T., Sugawara, H., Shibata, S., Abe, K., Ishikawa, S., Ohno, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05667-5 · Cited by 37
Shaping Up Mitochondria in Diabetic Nephropathy
Mise, K., Galvan, D. L., & Danesh, F. R. (2020) · Kidney360 · doi:10.34067/kid.0002352020 · Cited by 35
“Finally, kidney biopsy specimens of patients with DN have revealed increased staining in glomeruli for the mitophagy insufficiency marker p62 (73).”
BackgroundCarbon monoxide alleviates senescence in diabetic nephropathy by improving autophagy
Chen, L., Mei, G., Jiang, C., Cheng, X., Li, D., Zhao, Y., Chen, H., Wan, C., Yao, P., Gao, C., et al. (2021) · Cell Proliferation · doi:10.1111/cpr.13052 · Cited by 34
Mitochondrial Regulation of Diabetic Kidney Disease
Galvan, D. L., Mise, K., & Danesh, F. R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.745279 · Cited by 42
Recent advances in molecular mechanisms of acute kidney injury in patients with diabetes mellitus
Infante, B., Conserva, F., Pontrelli, P., Leo, S., Stasi, A., Fiorentino, M., Troise, D. E., Strologo, A. D., Alfieri, C., Gesualdo, L., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.903970 · Cited by 40
Kuwagata, S., Kume, S., Chin‒Kanasaki, M., Araki, H., Araki, S., Nakazawa, J., Sugaya, T., Koya, D., Haneda, M., Maegawa, H., et al. (2016) · Kidney International · doi:10.1016/j.kint.2016.06.036 · Cited by 33
Self-citationRaval, N., Jogi, H., Gondaliya, P., Kalia, K., & Tekade, R. K. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00094 · Cited by 34
Lysosome Depletion-Triggered Autophagy Impairment in Progressive Kidney Injury
Chen, X., Li, Z., Yang, C., Tang, J., Lan, H.-Y., & Liu, H. (2021) · Kidney Diseases · doi:10.1159/000515035 · Cited by 34
The Role of Autophagy in Anti-Cancer and Health Promoting Effects of Cordycepin
Chen, Y.-Y., Chen, C.-H., Lin, W.-C., Tung, C.-W., Chen, Y., Yang, S., Huang, B., & Chen, R.-J. (2021) · Molecules · doi:10.3390/molecules26164954 · Cited by 35
“Similar results were found in kidney biopsy samples from diabetic kidney disease patients with massive proteinuria, which showed reduced autophagy levels in podocytes [74].”
ResultOno, S., Kume, S., Yasuda‒Yamahara, M., Yamahara, K., Takeda, N., Chin‒Kanasaki, M., Araki, H., Sekine, O., Yokoi, H., Mukoyama, M., et al. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw463 · Cited by 30
“Periodic acid–Schiff (PAS) staining, hematoxylin and eosin (HE) staining, immunohistochemistry and immunofluorescence were performed as described previously [26].”
MethodInfluentialSelf-citationGlucose- and Non-Glucose-Induced Mitochondrial Dysfunction in Diabetic Kidney Disease
Ito, M., Gurumani, M. Z., Merscher, S., & Fornoni, A. (2022) · Biomolecules · doi:10.3390/biom12030351 · Cited by 35
Shi, L., Xiao, C., Zhang, Y., Xia, Y., Zha, H., Zhu, J., & Song, Z. (2022) · Renal Failure · doi:10.1080/0886022x.2022.2063744 · Cited by 33
Renoprotective effect of esculetin against ischemic acute kidney injury-diabetic comorbidity
Dagar, N., Habshi, T., Shelke, V., Jadhav, H. R., & Gaikwad, A. B. (2024) · Free Radical Research · doi:10.1080/10715762.2024.2313738 · Cited by 31
“…PiNK1 and Parkin expression are also linked with a suppressed expression and activation of autophagy proteins in tubular epithelial cells [57]. also, we observed increased colocalization of mitochondria with autophagosome after esculetin treatment, indicating enhanced mitophagosome…”
BackgroundLi, X., Li, Q., Jiang, X., Song, S., Zou, W., Yang, Q., Liu, S., Chen, S., & Wang, C. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01914-1 · Cited by 39
Ye, Z., Li, Z., & He, S.-Z. (2017) · Medical Science Monitor · doi:10.12659/msm.905336 · Cited by 33
“Abnormal ALP was closely associated with the progression of DR [16].”
BackgroundOrientin Protects Podocytes from High Glucose Induced Apoptosis through Mitophagy
Kong, Z., Che, K., Hu, J., Chen, Y., Wang, Y., Wang, X., Lü, W., Wang, Y., & Chi, J. (2020) · Chemistry & Biodiversity · doi:10.1002/cbdv.201900647 · Cited by 29
Podocyte Lysosome Dysfunction in Chronic Glomerular Diseases
Li, G., Kidd, J. M., & Li, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051559 · Cited by 32
Özkan, S., Işıldar, B., Erçin, M., Gezginci-Oktayoğlu, S., Konukoğlu, D., Neşetoğlu, N., Öncül, M., & Koyutürk, M. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03121-6 · Cited by 32
“The pathogenesis of glomerular damage with respect to podocytes has been associated with hypertrophy which is considered as an adaptation for the covering of naked GBM surface resulting from glomerular dilation, epithelial–mesenchymal transition, apoptosis and dysregulated autophagy [3, 5, 6].”
BackgroundResultHe, X., & Zeng, X. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s271290 · Cited by 28
“The decreased number and the destructed structure or function of podocytes, which is one of the components of the glomerular filtration barrier, are strongly related to the production of proteinuria.(3) High glucose (HG) can promote reactive oxygen species (ROS) release and apoptosis of podocytes, leading to podocytes…”
BackgroundLu, R., Chen, J., Liu, B., Lin, H., Bai, L., Zhang, P., Chen, D., Li, H., Li, J., Pang, Y., et al. (2020) · Phytotherapy Research · doi:10.1002/ptr.6772 · Cited by 30
“rently thought that autophagy is closely associated with the injury of mesangial cells, podocytes and renal tubular epithelial cells (Matsuda et al., 2018; Sureshbabu, Ryter, & Choi, 2015; Tagawa et al., 2016).”
BackgroundMa, L., Zhang, L., Li, J., Zhang, X., Xie, Y., Li, X., Yang, B., & Yang, H. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00745-z · Cited by 36
Urinary afamin levels are associated with the progression of diabetic nephropathy
Kaburagi, Y., Takahashi, E., Kajio, H., Yamashita, S., Yamamoto‐Honda, R., Shiga, T., Okumura, A., Goto, A., Fukazawa, Y., Seki, N., et al. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.034 · Cited by 29
Protective role of podocyte autophagy against glomerular endothelial dysfunction in diabetes
Yoshibayashi, M., Kume, S., Yasuda‒Yamahara, M., Yamahara, K., Takeda, N., Osawa, N., Chin‒Kanasaki, M., Nakae, Y., Yokoi, H., Mukoyama, M., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.02.088 · Cited by 26
Self-citationWang, B., Qian, J.-Y., Tang, T., Lin, L.-L., Yu, N., Guo, H., Ni, W., Lv, L.-L., Wen, Y., Li, Z., et al. (2021) · Diabetes · doi:10.2337/db21-0205 · Cited by 28
Chen, X., Wang, J., Lin, Y., Liu, Y., & Zhou, T. (2022) · Cells · doi:10.3390/cells11233913 · Cited by 29
“Podocyte autophagy deficiency may play a pathogenic role in the development of DKD into massive proteinuria [96].”
BackgroundThe Interplay of Autophagy and Oxidative Stress in the Kidney: What Do We Know?
Guo, H., & Bechtel‐Walz, W. (2023) · The Nephron journals/Nephron journals · doi:10.1159/000531290 · Cited by 38
Alghamdi, T. A., Majumder, S., Thieme, K., Batchu, S. N., White, K. E., Liu, Y., Brijmohan, A. S., Bowskill, B. B., Advani, S. L., Woo, M., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016111208 · Cited by 26
Xu, Y., Chen, X., Huang, J., Xu, C., & Xiong, Y. (2024) · International Urology and Nephrology · doi:10.1007/s11255-024-04038-0 · Cited by 30
“Insufficient autophagy in podocytes has been observed in diabetic patients with high levels of albuminuria, which aggravates proteinuria in DN [9, 10].”
Gao, C., Chen, J., Fan, F., Long, Y., Tang, S. J., Jiang, C., Wang, J., Xu, Y., & Xu, Y. (2019) · Mediators of Inflammation · doi:10.1155/2019/6207563 · Cited by 27
“[40] found defective autophagy and podocyte apoptosis in DN patients and mice with proteinuria; specifically, Atg5 knockout can accelerate diabetes-induced podocyte injury, filtration barrier destruction, and glomerular sclerosis [8].”
BackgroundJakubek, P., Pakula, B., Rossmeisl, M., Pinton, P., Rimessi, A., & Wieckowski, M. R. (2024) · Internal and Emergency Medicine · doi:10.1007/s11739-024-03700-w · Cited by 33
“Tagawa et al. showed that the level of p62/SQSTM1 protein was elevated in kidney biopsies from patients with diabetic nephropathy and massive proteinuria, suggesting defective lysosomal degradation [71].”
The Intertwining of Autophagy and the Ubiquitin Proteasome System in Podocyte (Patho)Physiology
Blume, L., & Meyer‐Schwesinger, C. (2021) · Cellular Physiology and Biochemistry · doi:10.33594/000000432 · Cited by 28
Kim, K., Hong, G.-L., Jung, D.-Y., Karunasagara, S., Jeong, W., & Jung, J. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00285-4 · Cited by 29
Zhang, Y., Yao, H., Li, C., Sun, W., Chen, X., Cao, Y. W., Liu, Y., Liu, Y., Chen, J., Qi, J., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6275505 · Cited by 27
“Lipid accumulation in kidneys led to dysfunction and loss of podocytes, which was a vital common pathway in diabetic nephropathy [23, 24].”
Research progress on the relationship between autophagy and chronic complications of diabetes
Ge, X., Wang, L., Fei, A., Ye, S., & Zhang, Q. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.956344 · Cited by 25
“However, high glucose could also contribute to resulting autophagy defects and proteinuria production (Tagawa et al., 2016).”
BackgroundGenetic susceptibility to diabetic kidney disease is linked to promoter variants of XOR
Wang, Q., Qi, H., Wu, Y., Yu, L., Bouchareb, R., Li, S., Lassén, E., Casalena, G., Stadler, K., Ebefors, K., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00776-0 · Cited by 28
Activation of the NLRP3 inflammasome by RAC1 mediates a new mechanism in diabetic nephropathy
Ying, C., Zhou, Z., Dai, J., Wang, M., Xiang, J., Sun, D., & Zhou, X. (2022) · Inflammation Research · doi:10.1007/s00011-021-01532-4 · Cited by 23
Sherkhane, B., Kalvala, A. K., Arruri, V. K., Khatri, D. K., & Singh, S. B. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23032 · Cited by 24
Xu, Y., Zhou, Q., Xin, W., Li, Z., Chen, L., & Wan, Q. (2016) · PeerJ · doi:10.7717/peerj.1888 · Cited by 23
SHIPping out diabetes—Metformin, an old friend among new SHIP2 inhibitors
Lehtonen, S. H. (2019) · Acta Physiologica · doi:10.1111/apha.13349 · Cited by 27
Sestrin2 Signaling Pathway Regulates Podocyte Biology and Protects against Diabetic Nephropathy
Ala, M. (2023) · Journal of Diabetes Research · doi:10.1155/2023/8776878 · Cited by 25
“Impaired autophagy, accumulation of dysfunctional lysosomes, and apoptosis were found in cultured podocytes exposed to serum from diabetic patients and in diabetic rats with massive proteinuria [66].”
BackgroundKong, Z., Xiao, M., Wang, B., Zhang, W., Che, K., Lv, W., Wang, Y., Huang, Y., Zhao, H. Q., Zhao, Y., et al. (2023) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x23500581 · Cited by 26
Activation of acetyl-CoA synthetase 2 mediates kidney injury in diabetic nephropathy
Lu, J., Li, X. Q., Chen, P. P., Zhang, J. X., Liu, L., Wang, G. H., Liu, X. Q., Jiang, T. T., Wang, M. Y., Liu, W. T., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.165817 · Cited by 27
“…autophagy deficiency and aberrant accumulation of the autophagy substrate p62 deteriorated podocyte loss and proteinuria in diabetic mice (35), indicating that impaired podocyte autophagy is involved in DN. Podocyte-specific autophagy-related protein 5 deletion contributes to endoplasmic…”
BackgroundWang, J., Hu, L., Chen, Y., Fu, T., Jiang, T., Jiang, A., & You, X. (2018) · Endocrine · doi:10.1007/s12020-018-1721-2 · Cited by 22
Khodir, S. A., Samaka, R. M., & Ameen, O. (2020) · International Journal of Nephrology · doi:10.1155/2020/7941861 · Cited by 206
“Podocyte-specific autophagy-deficient mice developed podocyte loss and massive proteinuria [7].”
BackgroundExercise Ameliorates Diabetic Kidney Disease in Type 2 Diabetic Fatty Rats
Monno, I., Ogura, Y., Xu, J., Koya, D., & Kitada, M. (2021) · Antioxidants · doi:10.3390/antiox10111754 · Cited by 26
Self-citationMechanisms and implications of podocyte autophagy in chronic kidney disease
Njeim, R., Merscher, S., & Fornoni, A. (2024) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00415.2023 · Cited by 23
Wang, X., Bakar, M. H. A., Liqun, S., Kassim, M. A., Shariff, K. A., & Karunakaran, T. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119560 · Cited by 24
Gong, J., Zhan, H., Li, Y., Zhang, W., Jin, J., & He, Q. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10585 · Cited by 21
“in the past few years, numerous studies have suggested that the activation of autophagy in podocytes may be a potential therapy used to prevent the progression of dn (22,23).”
BackgroundmTOR pathway: A key player in diabetic nephropathy progression and therapeutic targets
Shi, J., Liu, X., Jiao, Y., Tian, J., An, J., Zou, G., & Zhuo, L. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101260 · Cited by 30
“34 These findings suggest that impaired autophagy in podocytes may contribute to podocyte dysfunction and the progression of DN.”
Zhu, X., Shen, X., Lin, B., Fang, J., Jin, J., & He, Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.889008 · Cited by 22
Histone modification in podocyte injury of diabetic nephropathy
Wang, S., Zhang, X., Wang, Q., & Wang, R. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02247-7 · Cited by 22
“Study has demonstrated that in diabetic patients and rat, podocyte autophagy is decreased, and podocyte-specific autophagy-related gene-deficient rat would develop damaged lysosome function and produce massive proteinuria [35].”
BackgroundWang, X., Liu, Q., Kong, D., Long, Z., Guo, Y., Wang, S., Liu, R., & Hai, C. (2020) · Journal of Molecular Histology · doi:10.1007/s10735-020-09904-6 · Cited by 20
Lipotoxicity, Nutrient-Sensing Signals, and Autophagy in Diabetic Nephropathy
Kume, S., & Maegawa, H. (2020) · JMA Journal · doi:10.31662/jmaj.2020-0005 · Cited by 24
Self-citationCansby, E., Caputo, M., Gao, L., Kulkarni, N. M., Nerstedt, A., Ståhlman, M., Borén, J., Porosk, R., Soomets, U., Pedrelli, M., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.140483 · Cited by 21
“Autophagy is thought to be especially important for maintaining the homeostasis of postmitotic cells, such as podocytes, which have only limited capacity for regeneration and display a high level of basal autophagy (27, 52-54).”
BackgroundXie, Y., Qian, Y., Cao, X., Qiu, Y., Zeng, J., Cao, Y., Xie, Y., Meng, X., Huang, K., Yi, F., et al. (2024) · Advanced Science · doi:10.1002/advs.202308378 · Cited by 19
Tesfa, K. H., Gebeyehu, C. D., Ewunetie, A. T., Gugsa, E., Zewdie, A. N., Dessie, G., & Endale, H. T. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100397 · Cited by 32
Gu, T.-T., Zhang, D., Wan, Z.-Y., Li, T., Jiao, R., Chen, T., Zhao, X., & Kong, L. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111079 · Cited by 20
Metformin Protects against Podocyte Injury in Diabetic Kidney Disease
Lehtonen, S. H. (2020) · Pharmaceuticals · doi:10.3390/ph13120452 · Cited by 24
“Interestingly, individuals with T2D and massive proteinuria exhibit reduced autophagic activity in podocytes compared to individuals with low levels of proteinuria, suggesting that defective autophagy contributes to disease progression [75].”
BackgroundResultInfluentialLiu, S., Li, X., Wen, R., Chen, L., Yang, Q., Song, S., Xiao, G., Su, Z., & Wang, C. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106281 · Cited by 21
Pathogenesis and management of renal fibrosis induced by unilateral ureteral obstruction
Nan, Q. Y., Piao, S. G., Jin, J. Z., Chung, B. H., Yang, C. W., & Li, C. (2024) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.23.156 · Cited by 25
“Abnormalities in autophagy are implicated in a variety of kidney diseases [51].”
BackgroundConnexin 43‑autophagy loop in the podocyte injury of diabetic nephropathy
Ji, J., Zhao, Y., Chen, N., Yang, M., Zhu, X., Shi, H., Gan, W., & Zhang, A. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4335 · Cited by 19
Nutrient Sensor mTOR and OGT: Orchestrators of Organelle Homeostasis in Pancreatic β-Cells
Esch, N., Jo, S., Moore, M., & Alejandro, E. U. (2020) · Journal of Diabetes Research · doi:10.1155/2020/8872639 · Cited by 23
“However, disrupted lysophagy has been observed in diabetic mouse podocytes and contributes to their dysfunction during hyperglycemia [245].”
BackgroundGuo, W., Li, H., Li, Y., & Kong, W. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115025 · Cited by 23
Audzeyenka, I., Rogacka, D., Piwkowska, A., Angielski, S., & Jankowski, M. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-2949-5 · Cited by 18
Wang, X., Su, W., Ma, M., Zhu, L., Gao, R., Qin, C., Shao, S., Gao, D., Gao, J., & Zhang, Z. (2022) · Endokrynologia Polska · doi:10.5603/ep.a2022.0072 · Cited by 18
Shi, X., Chang, M., Zhao, M., Shi, Y., & Zhang, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113916 · Cited by 17
Ai, S., Li, Y., Zheng, H., Wang, Z., Liu, W., Tao, J., Li, Y., & Wang, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1275792 · Cited by 20
“Koya, Daisuke proved that dysfunctional podocyte autophagy worsens proteinuria (Tagawa et al., 2016).”
BackgroundCai, X., Wang, L., Wang, X., & Hou, F. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6298 · Cited by 17
“Proteinuria was separated from proteinuria podocytes and apoptosisoccursin glomerularbasement membrane (6,7).”
BackgroundState of the art – sirtuin 1 in kidney pathology – clinical relevance
Bielach-Bazyluk, A., Małyszko, J., Hryszko, T., & Zbroch, E. (2019) · Advances in Medical Sciences · doi:10.1016/j.advms.2019.04.005 · Cited by 17
Zhang, L., Li, W., Gong, M., Zhang, Z., Xue, X., Mao, J., Zhang, H., Li, S., Liu, X., Wu, F., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202200198r · Cited by 23
hucMSC‐sEVs‐Derived 14‐3‐3ζ Serves as a Bridge between YAP and Autophagy in Diabetic Kidney Disease
Yin, S., Liu, W., Ji, C., Zhu, Y. X., Shan, Y., Zhou, Z., Chen, W., Zhang, L., Sun, Z., Zhou, W., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3281896 · Cited by 19
“Podocytes, attached to the outside of the glomerular basement membrane (GBM), and their structural and functional changes are extremely important in the development and progression of DKD, which are mainly manifested in abnormal podocyte hypertrophy, disappearance, and apoptosis [4 – 6].”
Overexpression of KLF5 inhibits puromycin‑induced apoptosis of podocytes
Li, Y., Sui, X., Hu, X., & Hu, Z. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9366 · Cited by 18
“Numerous studies have demonstrated that well-managed blood glucose, blood pressure and blood lipid levels, and medicinal application of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, may postpone disease progression (8,9).”
The role of extracellular vesicles in podocyte autophagy in kidney disease
Sun, B.-C., Zhai, S.-B., Zhang, L., & Sun, G. (2021) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-020-00594-z · Cited by 18
Li, Z., An, N., Huang, X.-J., Yang, C., Wu, H.-L., Chen, X., Pan, Q., & Liu, H. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16593 · Cited by 20
Metadata
- Authors
- Tagawa, A., Yasuda, M., Kume, S., Yamahara, K., Nakazawa, J., Chin-Kanasaki, M., Araki, H., Araki, S.-I., Koya, D., Asanuma, K., Kim, E.-H., Haneda, M., Kajiwara, N., Hayashi, K., Ohashi, H., Ugi, S., Maegawa, H., & Uzu, T.
- Affiliations
- Shiga University of Medical Science (JP)
- Department of Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan
- Kanazawa Medical University (JP)
- Kyoto University (JP)
- Division of Nephrology, Juntendo University Faculty of Medicine, Bunkyo-ku, Tokyo, Japan
- Asahikawa Medical University (JP)
- Ikeda Municipal Hospital (JP)
- Corresponding author
- Kume, Shinji
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2015-09-17
- Volume
- 65
- Issue
- 3
- Pages
- 755-767
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2179291431
- Cited by
- 315
- References
- 53
- Citations by year
- 2026: 14 · 2025: 13 · 2024: 33 · 2023: 38 · 2022: 44 · 2021: 40 · 2020: 44 · 2019: 29 · 2018: 21 · 2017: 23 · 2016: 14 · 2015: 1
- FWCI
- 17.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (25713033, 26293217, 15K19511, 26670431)
- Takeda Science Foundation
- Banyu Life Science Foundation International
- Uehara Memorial Foundation
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- proteinuria, diabetic nephropathy, podocyte loss, lysosomal dysfunction, lysosomal homeostasis, high-fat diet-induced diabetes, apoptosis, diabetic serum
- MeSH terms
- Intravital Microscopy, Autophagy-Related Protein 5, Autophagy-Related Protein 7, Adult, Aged, Animals, Autophagy, Cell Line, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Female, Humans, Kidney, Lysosomes, Male, Membrane Proteins, Mice, Inbred C57BL, Mice, Transgenic, Microfilament Proteins, Microscopy, Electron, Scanning, Microtubule-Associated Proteins, Middle Aged, Proteinuria, Severity of Illness Index, Blotting, Western, RNA-Binding Proteins, Apoptosis, Mice, Knockout, Rats, Long-Evans, Microscopy, Electron, Transmission, Intracellular Signaling Peptides and Proteins, Podocytes, Mice, Rats, Young Adult, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.